is willow glp 1 fda approved New project announcement: HHS‑OIG taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing FDA approves Wegovy pill and

The vote came despite a highly critical review of the peptide from FDAs staff scientists, who said there was little data suggesting BPC-157 is effective for medical use

Precursor compounds like NAC may support endogenous glutathione synthesis effectively

doi:10.1021/acs.jmedchem.1c00565 Cao J, Belousoff MJ, Johnson RM, et al

With files from Jennifer La Grassa, The Canadian Press and Reuters

The spending increase is driven primarily by higher outpatient costs, an increase of $438 in the first year, likely reflecting monitoring visits for dose titration and managing side effects

The addition of data from AMPLITUDE-O trial to the seven-trial meta-analysis [5] showed that patients with type 2 diabetes who received GLP-1 agonists had a decreased risk of MACE and decreased individual components (stroke more than myocardial infarction), independently of the structure of these drugs (exendine-4 based or human analogs)